biotechnology sector; the other addresses leading companies and pioneering treatments in the race to develop new anti-viral drug therapies.
—A track nearly as large features 90 companies based in China (but with stock that trades on U.S. markets). This morning’s China panel includes a discussion of case studies and lessons learned, conducting effective due diligence, assessment of company accounting capabilities, legal considerations, and other topics.
—Roth also has organized a cleantech investing panel on the changing landscape in power production and distribution that includes a discussion of electric grid modernization and the influence of federal stimulus funds, demand-side management, and the role natural gas is expected to play in future power generation.
All told, 21 San Diego companies also are scheduled to make presentations:
Alphatec Holdings (NASDAQ: [[ticker:ATEC]])
Genoptix (NASDAQ: [[ticker:GXDX]])
Overland Storage (NASDAQ: [[ticker:OVRL]])
Qualcomm (NASDAQ: [[ticker:QCOM]])
Cytori Therapeutics (NASDAQ: [[ticker:CYTX]])
DexCom (NASDAQ: [[ticker:DXCM]])
NuVasive (NASDAQ: [[ticker:NUVA]])
Volcano (NASDAQ: [[ticker:VOLC]])
Cypress Bioscience (NASDAQ: [[ticker:CYPB]])
NexMed (NASDAQ: [[ticker:NEXM]])
Santarus (NASDAQ: [[ticker:SNTS]])
DivX (NASDAQ: [[ticker:DIVX]])
Maxwell Technologies (NASDAQ: [[ticker:MXWL]])
Anadys Pharmaceutical (NASDAQ: [[ticker:ANDS]])
Ardea Biosciences (NASDAQ: [[ticker:RDEA]])
Inovio Biomedical (NASDAQ: [[ticker:INO]])
Neurocrine Biosciences (NASDAQ: [[ticker:NBIX]])
Vical Inc. (NASDAQ: [[ticker:VICL]])
Sequenom (NASDAQ: [[ticker:SQNM]])
Halozyme Therapeutics (NASDAQ: [[ticker:HALO]])
Lifevantage (NASDAQ: [[ticker:LFVN]])
Senomyx (NASDAQ: [[ticker:SNMX]])